Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia.

[1]  R. Lyons,et al.  Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG , 2015, Case reports in hematology.

[2]  M. Robin,et al.  A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  A. Ganser,et al.  How I treat the acquired von Willebrand syndrome. , 2011, Blood.

[4]  G. Lippi,et al.  The use of recombinant activated factor VII in congenital and acquired von Willebrand disease. , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[5]  H. Döhner,et al.  Reversal of Acquired von Willebrand Disease after Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with High Risk Chronic Lymphocytic Leukemia. , 2004 .

[6]  Shaji K. Kumar,et al.  Acquired von Willebrand disease. , 2002, Mayo Clinic proceedings.

[7]  P. V. van Genderen,et al.  Acquired von Willebrand Syndrome: Data from an International Registry , 2000, Thrombosis and Haemostasis.

[8]  A. Federici.  Therapeutic approaches to acquired von Willebrand syndrome , 2000, Expert opinion on investigational drugs.

[9]  P. Mannucci,et al.  Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. , 1998, Blood.

[10]  P. Mannucci,et al.  Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies. , 1984, Blood.